Allogene Overland Biopharm Taps Cell Therapy Veteran Yao as CEO

Allogene Overland Biopharm Taps Cell Therapy Veteran Yao as CEO

Source: 
BioSpace
snippet: 

WuXi veteran Shuyuan Yao has been named chief executive officer of Allogene Overland Biopharm, a company formed by Allogene Therapeutics and Overland Pharmaceuticals in December to advance CAR-T cell therapies in China and other Asian markets.